Impact of Pharmaceutical Care in Diabetics Patients (IPCD)

Universidade Estadual da Paraiba

Status: Completed

Conditions: Diabetes Mellitus Type 2

Treatments: Behavioral: Intervention: Pharmaceutical Care

Study type: Interventional

Funder types: Other

Identifiers

NCT01580904

UEParaiba

Details and patient eligibility

About

The monitoring of diabetics by the pharmacist may contribute to the effectiveness of drug treatment and to improve their quality of life. This study will measure the impact of pharmacotherapeutic follow-up in diabetic patients. This will be a clinical trial, single blind, controlled, randomized, conducted in two units of pharmacies in Brazil. Only in the intervention group will be held the pharmacotherapeutic follow using a methodology called the practice of pharmaceutical care, which identifies and resolves problems related to drugs. The primary outcome is glycated hemoglobin, and secondary outcomes are baseline glucose, total cholesterol and its fractions (for example LDL), all these measures will be made in the intervention group and control group. Patients will be followed for 24 weeks, and the outcomes will be assessed up to 24 weeks. There will be a confidence interval of 95% and a significance of p <0.05, and will use the Student t test, chi-square analysis of variance (ANOVA) and others if necessary. Expects good results and serve as a model for other researchers.

Enrollment: 100 patients

Sex: All

Ages: 30 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Inclusion criteria:

• patients aged 30 years,
• diagnosed with type 2 diabetes,
• to make use of oral antidiabetic agents with or without insulin

Exclusion Criteria:

those who had infectious diseases during the research

• missed three consecutive interviews,
• suspended the hypoglycemic drug and medical order

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

100 participants in 2 patient groups

control group

No Intervention group

Description:

Patients will not be followed by the pharmacist.

Intervention group

Experimental group

Description:

Patients will be followed by the pharmacist by Pharmacotherapeutic monitoring and dosing parameters such as glucose and glycated hemoglobin. Intervention: Pharmaceutical Care

Treatment:

Behavioral: Intervention: Pharmaceutical Care